Apophysomyces variabilis as an emerging pathogen in Mainland China
Mycoses · 2023
DOI: 10.1111/myc.13605 ↗Kurz gefasst
Fallbericht in der Zeitschrift Mycoses, 2023. Verfasst von Xiu-Ying Li und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology and Venereology, The First Affiliated Hospital of Guangxi Medical University, Nanning, China. Hauptthemen laut MEDLINE: Mycobacterium tuberculosis, Mucorales, Mucormycosis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key R&D Program of China, Natural Science Foundation of Guangxi Province of China, Guangxi Key Laboratory of Tropical Fungi and Mycosis Research.
Abstract (Originalsprache)
Background
Mucormycosis is a rare form of invasive, rapidly progressive and lethal opportunistic fungal infection caused by Mucorales. Although Rhizopus arrhizus ( R. arrhizus ) is the most commonly isolated Mucorales worldwide, infections caused by Apophysomyces variabilis ( A. variabilis ) are increasing. Objectives and Methods We present a case of necrotizing fasciitis caused by A. variabilis in an immunocompetent woman. In order to further understand the characteristics of the strain isolated from the patient, we identified the strain through ITS sequencing, assessed the ability to tolerate salt concentrations and temperature conditions, in addition to performing in vitro drug susceptibility testing against common antifungal agents.
Results
The strain showed 98.76% identity with A. variabilis in the NCBI database, and it was found to tolerate higher temperatures and salt concentrations than previously reported strains. The strain was sensitive to amphotericin B and posaconazole, but not to voriconazole, itraconazole, 5‐fluorocytosine and echinocandins.
Conclusions
This case indicates that Mucorales caused by A. variabilis should be recognised as an emerging pathogen that can cause a high mortality rate in the absence of prompt diagnosis and proper treatment in China, aggressive surgical debridement combined with prompt and appropriate antifungal treatment may improve outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Dermatology and Venereology, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.
- Guangxi Key Laboratory of Mycosis Research and Prevention, Nanning, China.
- Department of Laboratory, Maternity and Child Health Care of Guangxi Zhuang Autonomous Region, Nanning, China.
- Department of Dermatology and Venereology, The Second Affiliated Hospital of Guangxi Medical University, Nanning, China.
- Fourth People's Hospital of Nanning, Nanning, China.
ORCID-Profile: Cun-Wei Cao
Förderung
- National Key R&D Program of China
- Natural Science Foundation of Guangxi Province of China
- Guangxi Key Laboratory of Tropical Fungi and Mycosis Research
Zitieren
APA
Li, X. Y., Wang, S. J., Huang, G. M., Zheng, D. Y., Al-Odaini, N., Pan, K. S., Zheng, Y. Q., & Cao, C. W. (2023). Apophysomyces variabilis as an emerging pathogen in Mainland China. Mycoses. https://doi.org/10.1111/myc.13605
Vancouver
Li XY, Wang SJ, Huang GM, Zheng DY, Al-Odaini N, Pan KS, et al. Apophysomyces variabilis as an emerging pathogen in Mainland China. Mycoses. 2023. doi:10.1111/myc.13605
BibTeX
@article{Li2023,
author = {Li, Xiu-Ying and Wang, Shuang-Jie and Huang, Guo-Mei and Zheng, Dong-Yan and Al-Odaini, Najwa and Pan, Kai-Su and Zheng, Yan-Qing and Cao, Cun-Wei},
title = {Apophysomyces variabilis as an emerging pathogen in Mainland China},
journal = {Mycoses},
year = {2023},
doi = {10.1111/myc.13605}
}
EUVIMED